Olix Pharmaceuticalsinc Stock Cash And Equivalents
| 226950 Stock | 15,400 60.00 0.39% |
OliX PharmaceuticalsInc fundamentals help investors to digest information that contributes to OliX PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of OliX Stock. The fundamental analysis module provides a way to measure OliX PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OliX PharmaceuticalsI stock.
OliX |
OliX PharmaceuticalsInc Company Cash And Equivalents Analysis
OliX PharmaceuticalsI's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current OliX PharmaceuticalsI Cash And Equivalents | 34.34 B |
Most of OliX PharmaceuticalsI's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OliX PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, OliX PharmaceuticalsInc has 34.34 B in Cash And Equivalents. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The cash and equivalents for all Republic of Korea stocks is significantly lower than that of the firm.
OliX Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OliX PharmaceuticalsI's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OliX PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing OliX PharmaceuticalsI by comparing valuation metrics of similar companies.OliX PharmaceuticalsI is currently under evaluation in cash and equivalents category among related companies.
OliX Fundamentals
| Return On Equity | -76.63 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (6.56) % | |||
| Current Valuation | 576.53 B | |||
| Shares Outstanding | 6.51 M | |||
| Shares Owned By Insiders | 29.21 % | |||
| Shares Owned By Institutions | 6.02 % | |||
| Price To Sales | 75.58 X | |||
| Revenue | 3.67 B | |||
| Gross Profit | 2.42 B | |||
| EBITDA | (15.1 B) | |||
| Net Income | (30.28 B) | |||
| Cash And Equivalents | 34.34 B | |||
| Total Debt | 20.38 B | |||
| Cash Flow From Operations | (19.05 B) | |||
| Number Of Employees | 67 | |||
| Beta | 0.99 | |||
| Market Capitalization | 152.89 B | |||
| Total Asset | 86.67 B | |||
| Z Score | 4.2 | |||
| Net Asset | 86.67 B |
About OliX PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OliX PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OliX PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OliX PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in OliX PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the OliX PharmaceuticalsInc information on this page should be used as a complementary analysis to other OliX PharmaceuticalsI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for OliX Stock analysis
When running OliX PharmaceuticalsI's price analysis, check to measure OliX PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OliX PharmaceuticalsI is operating at the current time. Most of OliX PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of OliX PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OliX PharmaceuticalsI's price. Additionally, you may evaluate how the addition of OliX PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |